Zynex, Inc. (ZYXI)
NASDAQ: ZYXI · Real-Time Price · USD
0.2940
+0.0140 (5.00%)
At close: Dec 19, 2025, 4:00 PM EST
0.2821
-0.0119 (-4.05%)
After-hours: Dec 19, 2025, 7:58 PM EST
Zynex Revenue
Zynex had revenue of $13.36M in the quarter ending September 30, 2025, a decrease of -73.26%. This brings the company's revenue in the last twelve months to $108.20M, down -44.13% year-over-year. In the year 2024, Zynex had annual revenue of $192.35M with 4.36% growth.
Revenue (ttm)
$108.20M
Revenue Growth
-44.13%
P/S Ratio
0.08
Revenue / Employee
$108,202
Employees
1,000
Market Cap
8.93M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 192.35M | 8.03M | 4.36% |
| Dec 31, 2023 | 184.32M | 26.16M | 16.54% |
| Dec 31, 2022 | 158.17M | 27.87M | 21.39% |
| Dec 31, 2021 | 130.30M | 50.18M | 62.63% |
| Dec 31, 2020 | 80.12M | 34.65M | 76.20% |
| Dec 31, 2019 | 45.47M | 13.56M | 42.47% |
| Dec 31, 2018 | 31.92M | 8.49M | 36.21% |
| Dec 31, 2017 | 23.43M | 10.12M | 76.01% |
| Dec 31, 2016 | 13.31M | 1.67M | 14.36% |
| Dec 31, 2015 | 11.64M | 524.00K | 4.71% |
| Dec 31, 2014 | 11.12M | -10.57M | -48.73% |
| Dec 31, 2013 | 21.68M | -17.98M | -45.33% |
| Dec 31, 2012 | 39.67M | 5.52M | 16.16% |
| Dec 31, 2011 | 34.15M | 10.06M | 41.78% |
| Dec 31, 2010 | 24.09M | 5.40M | 28.93% |
| Dec 31, 2009 | 18.68M | 6.92M | 58.80% |
| Dec 31, 2008 | 11.76M | 3.72M | 46.16% |
| Dec 31, 2007 | 8.05M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
ZYXI News
- 5 days ago - Zynex Financial Restructuring Puts Company on Path to Long-Term Success - PRNewsWire
- 4 weeks ago - Zynex, Inc. (ZYXI) Q3 2025 Earnings Call Prepared Remarks Transcript - Seeking Alpha
- 4 weeks ago - Zynex Reports Third Quarter 2025 Financial Results - PRNewsWire
- 5 weeks ago - Zynex Announces Strategic Initiatives: Engagement of Province, Appointment of Paul Aronzon to Board of Directors, and Formation of Special Committee - PRNewsWire
- 5 weeks ago - Zynex Sets Third Quarter 2025 Earnings Call - PRNewsWire
- 2 months ago - Zynex Announces Appointment of Bret Wise to Board of Directors as Audit Committee Chair - PRNewsWire
- 4 months ago - Zynex Announces Arrival of Steven Dyson as CEO and Appointment of New Leadership in Key Roles - PRNewsWire
- 4 months ago - Zynex, Inc. Investors: Company Investigated by the Portnoy Law Firm - GlobeNewsWire